FDA approves Eliquis for VTE prevention following hip/knee replacement: http://finance.yahoo.com/news/u-fda-approves-eliquis-apixaban-170000729.html This is Eliquis’ second approved indication in the US; the first (and larger) indication is stroke prevention in AF. Eliquis was approved in the EU for VTE prevention following hip/knee surgery way back in 2011 (#msg-61114160).